Omnicell's Tariff Exposure Meets Hospital Budget Reality in Tomorrow's Print
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Omnicell reports before the market open, meaning Day 0 represents the first full trading session where investors can react to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-28 | +$7.88 (+20.94%) | $3.82 (10.15%) | -$2.41 (-5.30%) | $4.76 (10.46%) |
| 2026-02-05 | -$7.61 (-16.30%) | $4.62 (9.90%) | -$2.01 (-5.14%) | $2.78 (7.11%) |
| 2025-10-30 | +$4.01 (+13.56%) | $3.61 (12.19%) | -$0.01 (-0.03%) | $1.63 (4.85%) |
| 2025-07-31 | +$1.31 (+4.41%) | $5.09 (17.14%) | -$1.25 (-4.03%) | $1.38 (4.45%) |
| 2025-05-06 | -$4.83 (-15.84%) | $3.94 (12.92%) | -$1.03 (-4.01%) | $1.44 (5.61%) |
| 2025-02-06 | -$4.95 (-11.15%) | $8.64 (19.47%) | +$0.73 (+1.85%) | $2.46 (6.24%) |
| 2024-10-30 | +$12.93 (+32.23%) | $10.59 (26.41%) | -$4.41 (-8.31%) | $5.07 (9.56%) |
| 2024-08-01 | +$9.64 (+33.00%) | $7.70 (26.36%) | +$0.37 (+0.95%) | $2.55 (6.56%) |
| Avg Abs Move | 18.43% | 16.82% | 3.70% | 6.86% |
Omnicell exhibits extreme volatility around earnings announcements, with an average absolute Day 0 move of 18.43%—significantly higher than typical stocks. The most recent earnings report on April 28, 2026, saw the stock surge 20.94% on Day 0 following the massive earnings beat, though it gave back 5.30% the following session. The February 2026 miss triggered a -16.30% decline on Day 0.
Historically, the stock has moved more than 10% on earnings day in seven of the past eight quarters, with moves ranging from 4.41% to 33.00%. The direction has been mixed but tilted positive in recent quarters, with four of the last eight Day 0 moves being gains. Day +1 follow-through has been more muted, averaging 3.70% in absolute terms, suggesting most of the reaction occurs immediately.
Investors should anticipate significant volatility, with historical patterns suggesting a move of 15-20% is well within normal range for this stock on earnings day.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 23) |
| Expected Move | $6.97 (16.84%) |
| Expected Range | $34.43 to $48.37 |
| Implied Volatility | 86.35% |
The options market is pricing an expected move of 16.84% (±$6.97) for the August expiration, which aligns closely with Omnicell's historical average Day 0 move of 18.43%. This suggests options traders are appropriately pricing the stock's characteristic earnings volatility, though the actual move could exceed this range given the stock's history of 20%+ swings in recent quarters.
Part 3: What Analysts Are Saying
Analysts maintain a bullish stance on Omnicell with a consensus rating of 4.56 out of 5.00, firmly in "Strong Buy" territory. The analyst community consists of 7 Strong Buy ratings and 2 Hold ratings among 9 total analysts covering the stock, with no sell recommendations.
The average price target of $59.50 implies substantial upside of 43.7% from the current price of $41.40, with estimates ranging from a low of $47.00 to a high of $70.00. This wide range reflects differing views on the sustainability of the company's recent profitability improvements and revenue growth trajectory.
However, sentiment has deteriorated slightly over the past month, with the number of Strong Buy ratings declining from 8 to 7 while Hold ratings increased from 1 to 2. The average recommendation has also slipped from 4.78 to 4.56, suggesting some analysts are taking a more cautious stance despite maintaining overall bullish views. This modest pullback in enthusiasm may reflect concerns about the flat year-over-year revenue comparison expected for Q2 or uncertainty about second-half momentum given the lowered Q3 estimates.
Part 4: Technical Picture
The Barchart Technical Opinion shows a Buy signal at 24%, representing a significant weakening from 48% Buy last week and 40% Buy last month. This deterioration in technical momentum heading into earnings suggests the stock has lost near-term buying pressure despite trading near recent levels.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal indicates mixed near-term momentum with neither bulls nor bears in clear control
- Medium-term (50% Buy): Neutral-to-positive reading suggests the intermediate trend remains constructive but lacks conviction
- Long-term (Hold): Neutral signal reflects an absence of strong directional bias in the longer-term trend structure
Minimum strength with Weakest direction characterizes the current trend environment, indicating OMCL lacks robust momentum heading into this high-volatility event and could be vulnerable to sharp moves in either direction depending on results.
The stock is trading at $41.40, positioned above its 5-day moving average of $41.36 and well above its 100-day ($40.11) and 200-day ($40.29) moving averages, confirming the longer-term uptrend remains intact. However, the stock has fallen below its 10-day ($42.76), 20-day ($43.86), and 50-day ($42.39) moving averages, indicating recent weakness and a loss of short-term momentum.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $41.36 | 50-Day MA | $42.39 |
| 10-Day MA | $42.76 | 100-Day MA | $40.11 |
| 20-Day MA | $43.86 | 200-Day MA | $40.29 |
Key resistance now sits at the 20-day moving average of $43.86, while support appears at the 200-day moving average of $40.29. The stock's position below most short-term moving averages but above longer-term trend lines suggests a consolidation phase. With technical momentum weakening into a historically volatile earnings event and the stock lacking strong directional conviction, the setup is neutral-to-cautious. A strong earnings beat could propel shares back above near-term resistance levels, while any disappointment could test the 200-day moving average support given the stock's tendency for outsized post-earnings moves.